We are live on ! Find out more
CABA icon

Cabaletta Bio
CABA

55 hedge funds and large institutions have $17.8M invested in Cabaletta Bio in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.59% less ownership

Funds ownership: 73.71% → 68.12% (-5.6%)

11% less funds holding

Funds holding: 62 → 55 (-7)

39% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 18

52% less capital invested

Capital invested by funds: $36.9M → $17.8M (-$19.1M)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

Holders
55
Holders Change
-7
Holders Change %
-11.29%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
18
Closed
12
Calls
$1K
Puts
–
Net Calls
+$1K
Net Calls Change
-$894K

Top Buyers

Rank Fund Capital Flow
1
DAM
DLD Asset Management
New York
+$349K
2
SC
Samlyn Capital
New York
+$215K
3
PSC
Piper Sandler & Co
Minnesota
+$205K
4
Renaissance Technologies
Renaissance Technologies
New York
+$192K
5
BCM
Bridgeway Capital Management
Texas
+$187K

Top Sellers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.47M
2
O
OrbiMed
New York
-$1.17M
3
Citadel Advisors
Citadel Advisors
Florida
-$312K
4
CI Investments Inc
CI Investments Inc
Ontario, Canada
-$262K
5
Millennium Management
Millennium Management
New York
-$174K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$65K +$2.97K +2,100 +4%
Victory Capital Management
27
Victory Capital Management
Texas
$45K +$59 +42 +0.1%
V
28
Veritable
Delaware
$39K – – –
Northern Trust
29
Northern Trust
Illinois
$31K – – –
CM
30
Crestline Management
Texas
$23K +$30.9K +21,881 New
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$21K – – –
Bank of New York Mellon
32
Bank of New York Mellon
New York
$20K -$5.45K -3,852 -17%
Bank of America
33
Bank of America
North Carolina
$16K -$24.2K -17,132 -53%
Barclays
34
Barclays
United Kingdom
$16K -$786 -556 -4%
Goldman Sachs
35
Goldman Sachs
New York
$15K +$122 +86 +0.6%
HSBC Holdings
36
HSBC Holdings
United Kingdom
$14K -$2.6K -1,836 -12%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$13K -$22.1K -15,609 -56%
IWM
38
IHT Wealth Management
Illinois
$13K – – –
Jane Street
39
Jane Street
New York
$12K +$15.8K +11,158 New
BC
40
BIT Capital
Germany
$10.6K – – –
TRCT
41
Tower Research Capital (TRC)
New York
$10K -$12.6K -8,886 -48%
Osaic Holdings
42
Osaic Holdings
Arizona
$7K -$1.41K -1,000 -13%
Simplex Trading
43
Simplex Trading
Illinois
$4K -$21.3K -15,076 -77%
Wells Fargo
44
Wells Fargo
California
$4K +$168 +119 +3%
JP Morgan Chase
45
JP Morgan Chase
New York
$2K -$2.98K -2,110 -57%
EWM
46
Endurance Wealth Management
Rhode Island
$1K – – –
Federated Hermes
47
Federated Hermes
Pennsylvania
$1K +$1.43K +1,008 +677%
FDCDDQ
48
Federation des caisses Desjardins du Quebec
Quebec, Canada
$360 – – –
Point72 Asset Management
49
Point72 Asset Management
Connecticut
– -$1.47M -725,000 Closed
O
50
OrbiMed
New York
– -$1.17M -577,509 Closed
1
2
3

CABA Hedge Fund Activity: Q2 2022 in Review

55 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cabaletta Bio (CABA) for Q2 2022, worth a combined $17.8M — down 52% from $36.9M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of CABA and 5 opened new positions — a net loss of 7 holders — while 18 trimmed existing stakes and 11 added.

The largest buyer was DLD Asset Management, opening a new position worth an estimated $349K. The largest seller was Point72 Asset Management, exiting entirely with an estimated $1.47M sold.

  • 55 institutional investors held Cabaletta Bio (CABA) as of Q2 2022, down from 62 in Q1 2022.
  • Funds reported $17.8M of Cabaletta Bio stock for Q2 2022, down 52% quarter-over-quarter.
  • 5 funds opened new Cabaletta Bio positions in Q2 2022 and 12 closed out, a net change of -7 holders.
  • The largest Cabaletta Bio buyer in Q2 2022 was DLD Asset Management, an estimated $349K added.
  • The largest Cabaletta Bio seller in Q2 2022 was Point72 Asset Management, an estimated $1.47M sold.

Based on aggregated 13F filings for Q2 2022.